2021 FDA Litumellano tse Ncha tsa Lithethefatsi 1Q-3Q

Boqapi bo tsamaisa tsoelopele.Ha ho tluoa boqaping ba nts'etsopele ea litlhare tse ncha le lihlahisoa tsa baeloji ea kalafo, Setsi sa FDA sa Tlhahlobo le Lipatlisiso tsa Lithethefatsi (CDER) se ts'ehetsa indasteri ea meriana mohatong o mong le o mong oa ts'ebetso.Ka kutloisiso ea eona ea mahlale a sebelisitsoeng ho theha lihlahisoa tse ncha, liteko le lits'ebetso tsa tlhahiso, le mafu le maemo ao lihlahisoa tse ncha li etselitsoeng ho alafa, CDER e fana ka likeletso tsa mahlale le tsa taolo tse hlokahalang ho tlisa liphekolo tse ncha 'marakeng.
Ho fumaneha ha meriana e mecha le lihlahisoa tsa likokoana-hloko hangata ho bolela mekhoa e mecha ea phekolo bakeng sa bakuli le tsoelo-pele ea tlhokomelo ea bophelo bakeng sa sechaba sa Amerika.Ka lebaka lena, CDER e ts'ehetsa boiqapelo 'me e bapala karolo ea bohlokoa ho thusa ho ntšetsa pele nts'etsopele ea lithethefatsi tse ncha.
Selemo se seng le se seng, CDER e amohela mefuta e mengata e fapaneng ea litlhare tse ncha le lihlahisoa tsa baeloji:
1. Tse ling tsa lihlahisoa tsena ke lihlahisoa tse ncha tseo ho seng mohla li kileng tsa sebelisoa ho tsa bongaka.Ka tlase ke lethathamo la mekhatlo e mecha ea limolek'hule le lihlahisoa tse ncha tsa kalafo tse amohetsoeng ke CDER ka 2021. Lethathamo lena ha le na liente, lihlahisoa tse sa pheleng hantle, mali le lihlahisoa tsa mali, tse tsoang ho plasma, cellular le gene therapy kapa lihlahisoa tse ling tse amohetsoeng ka 2021 Setsi sa Tlhahlobo le Lipatlisiso tsa Biologics.
2. Tse ling li tšoana, kapa li amana le lihlahisoa tse amohetsoeng pele, 'me li tla qothisana lehlokoa le lihlahisoa tseo 'marakeng.Sheba Drugs@FDA bakeng sa tlhahisoleseling mabapi le litlhare tsohle tse lumelletsoeng tsa CDER le lihlahisoa tsa baeloji.
Lithethefatsi tse ling li khetholloa e le mekhatlo e mecha ea limolek'hule ("NMEs") molemong oa tlhahlobo ea FDA.Bongata ba lihlahisoa tsena li na le likarolo tse sebetsang tse so amoheloeng ke FDA nakong e fetileng, e ka ba motsoako o le mong oa moriana kapa e le karolo ea motsoako oa sehlahisoa;hangata lihlahisoa tsena li fana ka liphekolo tse ncha tsa bohlokoa ho bakuli.Lithethefatsi tse ling li khetholloa e le li-NME bakeng sa merero ea tsamaiso, empa leha ho le joalo li na le likarolo tse sebetsang tse amanang haufi-ufi le lihlopha tse sebetsang lihlahisoa tse kileng tsa amoheloa ke FDA.Mohlala, CDER e hlopha lihlahisoa tsa baeloji tse rometsoeng kopong tlas'a karolo ea 351 (a) ea Molao oa Ts'ebeletso ea Bophelo bo Botle e le li-NME molemong oa tlhahlobo ea FDA, ho sa tsotelehe hore na Setsi se kile sa amohela karolo e amanang le sehlahisoa se seng.Khethollo ea FDA ea sethethefatsi e le "NME" molemong oa tlhahlobo e fapane le qeto ea FDA ea hore na sehlahisoa sa lithethefatsi ke "setsi se secha sa lik'hemik'hale" kapa "NCE" ho latela moelelo oa Federal Food, Drug, and Cosmetic Act.

Che. Lebitso la Lithethefatsi Motsoako o sebetsang Letsatsi la Tumello Tšebeliso e amohetsoeng ke FDA ka letsatsi la tumello *
37 Exkivity mobocertinib 9/15/2021 Ho alafa mofetše oa matšoafo oa sele e tsoetseng pele kapa oa metastatic oo e seng o monyane ka epidermal growth factor receptor exon 20 insertion liphetoho
36 Skytrofa lonapegsomatropin-tcgd 8/25/2021 Ho phekola boemo bo bokhuts'oane ka lebaka la tlhahiso e sa lekaneng ea "endogenous growth hormone".
35 Korsuva difelikefalin 8/23/2021 Ho phekola pruritus e leka-lekaneng ho isa ho e matla e amanang le lefu le sa foleng la liphio lichabeng tse itseng
34 Welireg belzutifan 8/13/2021 Ho phekola lefu la von Hippel-Lindau tlas'a maemo a itseng
33 Nexviazyme avalglucosidase alfa-ngpt 8/6/2021 Ho alafa lefu la Pompe le qalang morao
Tsebiso ea boralitaba
32 Saphnelo anifrolumab-fnia 7/30/2021 Ho alafa systemic lupus erythematousus e itekanetseng ho isa ho e matla mmoho le kalafo e tlwaelehileng
31 Bylvay odevixibat 7/20/2021 Ho phekola ho hlohlona
30 Rezurock belumosudil 7/16/2021 Ho alafa lefu le sa foleng la graft-vers-host kamora ho hloleha ha bonyane mela e 'meli ea pele ea systemic therapy
29 fexidazole fexidazole 7/16/2021 Ho phekola trypanosomiasis ea batho ea Afrika e bakoang ke kokoana-hloko ea Trypanosoma brucei gambiense
28 Kerendia finerenone 7/9/2021 Ho fokotsa kotsi ea mathata a liphio le pelo ho lefu la liphio le sa foleng le amanang le lefu la tsoekere la mofuta oa 2
27 Rylaze asparaginase erwinia chrysanthemi (recombinant) -rywn 6/30/2021 Ho phekola acute lymphoblastic leukemia le lymphoblastic lymphoma ho bakuli ba alejiki ho lihlahisoa tsa asparaginase tse tsoang ho E. coli, e le karolo ea mokhoa oa phekolo ea lik'hemik'hale.
Tsebiso ea boralitaba
26 Aduhelm aducanumab-avwa 6/7/2021 Ho phekola lefu la Alzheimer
Tsebiso ea boralitaba
25 Brexafemme ibrexafungerp 6/1/2021 Ho phekola vulvovaginal candidiasis
24 Lybalvi olanzapine le samidorphan 5/28/2021 Ho phekola schizophrenia le likarolo tse ling tsa lefu la ho ferekana kelellong
23 Truseltiq Infigratinib 5/28/2021 Ho phekola cholangiocarcinoma eo lefu la eona le finyellang litekanyetso tse itseng
22 Lumakras sotorasib 5/28/2021 Ho phekola mefuta e meng ea mofetše oa matšoafo oa sele e seng nyane
Tsebiso ea boralitaba
21 Pylarify piflufolastat F18 5/26/2021 Ho tsebahatsa maqeba a antigen-positive a prostate-specific membrane mofetšeng oa senya
20 Rybrevant amivantamab-vmjw 5/21/2021 Ho phekola mofets'e oa mofets'e o seng nyane oa sele ea matšoafo
Tsebiso ea boralitaba
19 Empaveli pegcetacoplan 5/14/2021 Ho phekola paroxysmal nocturnal hemoglobinuria
18 Zynlonta loncastuximab tesirine-lpyl 4/23/2021 Ho alafa mefuta e itseng ea ho khutlela morao kapa ho refractory e kholo ea B-cell lymphoma
17 Jemperli dostarlimab-gxly 4/22/2021 Ho phekola kankere ea endometrial
Tsebiso ea boralitaba
16 Nextstellis drospirenone le estetrol 4/15/2021 Ho thibela bokhachane
15 Qelbree viloxazine 4/2/2021 Ho alafa kgaello ya kgatello ya maikutlo
14 Zegalogue dasiglucagon 3/22/2021 Ho phekola hypoglycemia e matla
13 Ponvory ponesimod 3/18/2021 Ho phekola mefuta e khutlelang morao ea multiple sclerosis
12 Fotivda tivozanib 3/10/2021 Ho phekola renal cell carcinoma
11 Azstarys serdexmethylphenidate le 3/2/2021 Ho alafa kgaello ya kgatello ya maikutlo
dexmethylphenidate
10 Pepaxto melphalan flufenamide 2/26/2021 Ho phekola ho khutlela morao kapa ho hanyetsa multiple myeloma
9 Nulibry fosdenopterine 2/26/2021 Ho fokotsa kotsi ea ho shoa ha molybdenum cofactor Type A
Tsebiso ea boralitaba
8 Li-Amondys 45 casimersen 2/25/2021 Ho phekola Duchenne muscular dystrophy
Tsebiso ea boralitaba
7 Cosela trilacicilib 2/12/2021 Ho fokotsa khatello ea myelosuppression e bakoang ke chemotherapy ho mofetše o monyane oa lisele tsa matšoafo
Tsebiso ea boralitaba
6 Evkeeza evinacumab-dgnb 2/11/2021 Ho phekola hypercholesterolemia ea malapa homozygous
5 Ukoniq seboko 2/5/2021 Ho phekola marginal zone lymphoma le follicular lymphoma
4 Tepmetko tepotinib 2/3/2021 Ho alafa mofetše oa matšoafo oa sele e seng nyane
3 Lupkynis Voclosporin 1/22/2021 Ho phekola lupus nephritis
Liteko tsa Lithethefatsi Snapshot
2 Cabenuva cabotegravir le rilpivirine (li phuthetsoe hammoho) 1/21/2021 Ho alafa HIV
Tsebiso ea boralitaba
Liteko tsa Lithethefatsi Snapshot
1 Verquvo verciguat 1/19/2021 Ho fokotsa kotsi ea lefu la pelo le ho kena sepetlele bakeng sa ho hloleha ha pelo ho sa foleng
Liteko tsa Lithethefatsi Snapshot

 

"Tsebeliso e amohetsoeng ke FDA" e thathamisitsoeng sebakeng sena sa Marang-rang ke molemong oa tlhahiso feela.Ho bona dipehelo tse dumelletsweng ke FDA tsa tshebediso [mohlala, matshwao,(ba)ahi,(ba)(ba)api,(di)regine ya ho noa bakeng sa se seng le se seng sa dihlahiswa tsena, bona Boitsebiso ba moraorao bo dumelletsweng ke FDA.
Qolla ho tsoa webosaeteng ea FDA:https://www.fda.gov/drugs/new-drugs-fda-cders-new-molecular-entities-and-new-therapeutic-biological-products/novel-drug-approvals-2021


Nako ea poso: Sep-27-2021